Artery Catheterizations Articles & Analysis: Older
2 news found
Adult heart failure trial to complete in 2020 with potential market entry in 2021 Trial to be conducted at Imperial College London’s Royal Brompton, UK Celixir, a private company discovering and developing lifesaving regenerative medicines, today announced it has received formal clinical trial application (CTA) approval from the Medicines and Healthcare Products Regulatory Agency to ...
Food and Drug Administration (FDA) has granted market clearance to Rex Medical’s bioresorbable Closer Vascular Sealing System (VSS) to achieve rapid hemostasis of femoral artery catheterizations. The vascular closure device consists of an insertion sheath, dilator and an implant contained in a delivery system. ...